Neuropathologic analysis of Lewy-related α-synucleinopathy in olfactory mucosa

Neuropathology

Volumn 33, Issue 1, 2013, Pages 47-58

  Funabe, Sayaka ^a,b   Takao, Masaki ^a   Saito, Yuko ^c   Hatsuta, Hiroyuki ^a   Sugiyama, Mikiko ^a   Ito, Shinji ^a   Kanemaru, Kazutomi ^a   Sawabe, Motoji ^a   Arai, Tomio ^a   Mochizuki, Hideki ^d   Hattori, Nobutaka ^b   Murayama, Shigeo ^a  

^a Tokyo Metropolitan Geriatric Hospital and Institute of Gerontology   (Japan)

^b JUNTENDO UNIVERSITY   (Japan)

^c National Center Hospital of Neurology and Psychiatry   (Japan)

^d OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

synuclein; Lewy body; Neuropathology; Olfactory mucosa; Parkinson's disease

Indexed keywords

ALPHA SYNUCLEIN;

AGED; ARTICLE; AUTOPSY; BRAIN NERVE CELL; CENTRAL NERVOUS SYSTEM; DIFFUSE LEWY BODY DISEASE; FEMALE; GERIATRIC HOSPITAL; GLOMERULITIS; GRANULAR CELL; HUMAN; LAMINA PROPRIA; LEWY BODY; LEWY RELATED ALPHA SYNUCLEINOPATHY; MAJOR CLINICAL STUDY; MALE; NERVE FIBER; NEUROPATHOLOGY; OLFACTORY BULB; OLFACTORY EPITHELIUM; OLFACTORY RECEPTOR; PARKINSON DISEASE; PERIPHERAL NERVOUS SYSTEM; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION;

AGED; AGED, 80 AND OVER; ALPHA-SYNUCLEIN; ALZHEIMER DISEASE; BRAIN; FEMALE; HUMANS; LEWY BODIES; LEWY BODY DISEASE; MALE; OLFACTORY MUCOSA; PARKINSON DISEASE;

EID: 84873257019     PISSN: 09196544     EISSN: 14401789     Source Type: Journal    
DOI: 10.1111/j.1440-1789.2012.01329.x     Document Type: Article

References (49)

1. Baba M, Nakajo S, Tu PH etal. Aggregation of alpha-synuclein in Lewy bodies of sporadic Parkinson's disease and dementia with Lewy bodies. Am J Pathol 1998; 152: 879-884.
2. Spillantini MG, Crowther RA, Jakes R, Hasegawa M, Goedert M. alpha-Synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with Lewy bodies. Proc Natl Acad Sci U S A 1998; 95: 6469-6473.
3. Goedert M, Spillantini MG, Davies SW. Filamentous nerve cell inclusions in neurodegenerative diseases. Curr Opin Neurobiol 1998; 8: 619-632.
4. Ogunnyi A, Akang EE, Gureje O etal. Dementia with Lewy bodies in a Nigerian: a case report. Int Psychogeriatr 2002; 14: 211-218.
5. Takao M, Ghetti B, Yoshida H etal. Early-onset dementia with Lewy bodies. Brain Pathol 2004; 14: 137-147.
6. Braak H, Ghebremedhin E, Rub U, Bratzke H, Del Tredici K. Stages in the development of Parkinson's disease-related pathology. Cell Tissue Res 2004; 318: 121-134.
7. Braak H, Sastre M, Bohl JR, de Vos RA, Del Tredici K. Parkinson's disease: lesions in dorsal horn layer I, involvement of parasympathetic and sympathetic pre- and postganglionic neurons. Acta Neuropathol 2007; 113: 421-429.
8. Braak H, Braak E. Pathoanatomy of Parkinson's disease. J Neurol 2000; 247 (Suppl 2): II3-I10.
9. Braak H, Del Tredici K, Rub U, de Vos RA, Jansen Steur EN, Braak E. Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol Aging 2003; 24: 197-211.
10. Del Tredici K, Rub U, De Vos RA, Bohl JR, Braak H. Where does Parkinson disease pathology begin in the brain? J Neuropathol Exp Neurol 2002; 61: 413-426.
11. Sengoku R, Saito Y, Ikemura M etal. Incidence and extent of Lewy body-related alpha-synucleinopathy in aging human olfactory bulb. J Neuropathol Exp Neurol 2008; 67: 1072-1083.
12. Ponsen MM, Stoffers D, Booij J, van Eck-Smit BL, Wolters ECh, Berendse HW. Idiopathic hyposmia as a preclinical sign of Parkinson's disease. Ann Neurol 2004; 56: 173-181.
13. Haehner A, Boesveldt S, Berendse HW etal. Prevalence of smell loss in Parkinson's disease - a multicenter study. Parkinsonism Relat Disord 2009; 15: 490-494.
14. Daniel SE, Hawkes CH. Preliminary diagnosis of Parkinson's disease by olfactory bulb pathology. Lancet 1992; 340 (8812): 186.
15. Pearce RK, Hawkes CH, Daniel SE. The anterior olfactory nucleus in Parkinson's disease. Mov Disord 1995; 10: 283-287.
16. Beach TG, White CL 3rd, Hladik CL etal. Olfactory bulb alpha-synucleinopathy has high specificity and sensitivity for Lewy body disorders. Acta Neuropathol 2009; 117: 169-174.
17. Parkkinen L, Silveira-Moriyama L, Holton JL, Lees AJ, Revesz T. Can olfacotry bulb biopsy be justified for the diagnosis of Parkinson's disease? Comments on 'olfactory bulb α-synucleinopathy has specificity and sensitivity for Lewy body disorders'. Acta Neuropathol 2009; 117 (2): 213-214.
18. Jellinger KA. Olfactory bulb α-synucleinopathy has specificity and sensitivity for Lewy body disorders. Acta Neuropathol 2009; 117 (2): 215-216.
19. Duda JE, Shah U, Arnold SE, Lee VM, Trojanowski JQ. The expression of alpha-, beta-, and gamma-synucleins in olfactory mucosa from patients with and without neurodegenerative diseases. Exp Neurol 1999; 160: 515-522.
20. Arnold SE, Lee EB, Moberg PJ etal. Olfactory epithelium amyloid-beta and paired helical filament-tau pathology in Alzheimer disease. Ann Neurol 2010; 67: 462-469.
21. Witt M, Bormann K, Gudziol V etal. Biopsies of olfactory epithelium in patients with Parkinson's disease. Mov Disord 2009; 24: 906-914.
22. Fumimura Y, Ikemura M, Saito Y etal. Analysis of the adrenal gland is useful for evaluating pathology of the peripheral autonomic nervous system in Lewy body disease. J Neuropathol Exp Neurol 2007; 66: 354-362.
23. Saito Y, Ruberu NN, Sawabe M etal. Staging of argyrophilic grains: an age-associated tauopathy. J Neuropathol Exp Neurol 2004; 63: 911-918.
24. Saito Y, Ruberu NN, Sawabe M etal. Lewy body-related alpha-synucleinopathy in aging. J Neuropathol Exp Neurol 2004; 63: 742-749.
25. Saito Y, Kawashima A, Ruberu NN etal. Accumulation of phosphorylated alpha-synuclein in aging human brain. J Neuropathol Exp Neurol 2003; 62: 644-654.
26. Ikemura M, Saito Y, Sengoku R etal. Lewy body pathology involves cutaneous nerves. J Neuropathol Exp Neurol 2008; 67: 945-953.
27. McKeith IG, Galasko D, Kosaka K etal. Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. Neurology 1996; 47: 1113-1124.
28. Folstein MF, Folstein SE, McHugh PR. 'Mini-mental state'. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975; 12: 189-198.
29. Hasegawa K Inoue K, Moriya K. An investigation of dementia rating scale for the elderly. Seishin Igaku 1974; 16: 965-969.
30. Hosokawa T, Yamada Y, Isagoda A, Nakamura R. Psychometric equivalence of the Hasegawa Dementia Scale-Revised with the Mini-Mental State Examination in stroke patients. Percept Mot Skills 1994; 79: 664-666.
31. Lawton MP, Brody EM. Assessment of older people: self-maintaining and instrumental activities of daily living. Gerontologist 1969; 9: 179-186.
32. Morris JC. The Clinical Dementia Rating (CDR): current version and scoring rules. Neurology 1993; 43: 2412-2414.
33. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984; 34: 939-944.
34. McKeith IG, Dickson DW, Lowe J etal. Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium. Neurology 2005; 65: 1863-1872.
35. Gallyas F. Silver staining of Alzheimer's neurofibrillary changes by means of physical development. Acta Morphol Acad Sci Hung 1971; 19: 1-8.
36. Fujiwara H, Hasegawa M, Dohmae N etal. alpha-Synuclein is phosphorylated in synucleinopathy lesions. Nat Cell Biol 2002; 4: 160-164.
37. Braak H, Braak E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol 1991; 82: 239-259.
38. Braak H, Alafuzoff I, Arzberger T, Kretzschmar H, Del Tredici K. Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry. Acta Neuropathol 2006; 112: 389-404.
39. Murayama S, Saito Y. Neuropathological diagnostic criteria for Alzheimer's disease. Neuropathology 2004; 24: 254-260.
40. Consensus recommendations for the postmortem diagnosis of Alzheimer's disease. The National Institute on Aging, and Reagan Institute Working Group on Diagnostic Criteria for the Neuropathological Assessment of Alzheimer's Disease. Neurobiol Aging 1997; 18: S1-S2.
41. Hyman BT, Trojanowski JQ. Consensus recommendations for the postmortem diagnosis of Alzheimer disease from the National Institute on Aging and the Reagan Institute Working Group on diagnostic criteria for the neuropathological assessment of Alzheimer disease. J Neuropathol Exp Neurol 1997; 56: 1095-1097.
42. Jellinger KA. Dementia with grains (argyrophilic grain disease). Brain Pathol 1998; 8: 377-386.
43. Jellinger KA, Bancher C. Senile dementia with tangles (tangle predominant form of senile dementia). Brain Pathol 1998; 8: 367-376.
44. Kosaka K. Diffuse neurofibrillary tangles with calcification: a new presenile dementia. J Neurol Neurosurg Psychiatry 1994; 57: 594-596.
45. Hawkes CH, Doty RL. The Neurology of Olfaction. Cambridge, UK: Cambridge University Press, 2009; 16-21.
46. Hawkes CH, Del Tredici K, Braak H. Parkinson's disease: a dual-hit hypothesis. Neuropathol Appl Neurobiol 2007; 33: 599-614.
47. Graziadei PP, Okano M. Neuronal degeneration and regeneration in the olfactory epithelium of pigeon following transection of the first cranial nerve. Acta Anat (Basel) 1979; 104: 220-236.
48. Graziadei PP, Monti Graziadei AG. Regeneration in the olfactory system of vertebrates. Am J Otolaryngol 1983; 4: 228-233.
49. Ubeda-Bañon I, Saiz-Sanchez D, de la Rosa-Prieto C, Argandoña-Palacios L, Garcia-Muñozguren S, Martinez-Marcos A. alpha-Synucleinopathy in the human olfactory system in Parkinson's disease: involvement of calcium-binding protein- and substance P-positive cells. Acta Neuropathol 2010; 119: 723-735.